CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene dependent mitogenic responses of mast cells.
Cysteinyl leukotrienes (cys-LTs) induce inflammation through 2 G protein-coupled receptors (GPCRs), CysLT(1) and CysLT(2), which are coexpressed by most myeloid cells. Cys-LTs induce proliferation of mast cells (MCs), transactivate c-Kit, and phosphorylate extracellular signal-regulated kinase (ERK). Although MCs express CysLT(2), their responses to cys-LTs are blocked by antagonists of CysLT(1). We demonstrate that CysLT(2) interacts with CysLT(1), and that knockdown of CysLT(2) increases CysLT(1) surface expression and CysLT(1)-dependent proliferation of cord blood-derived human MCs (hMCs). Cys-LT-mediated responses were absent in MCs from mice lacking CysLT(1) receptors, but enhanced by the absence of CysLT(2) receptors. CysLT(1) and CysLT(2) receptors colocalized to the plasma membranes and nuclei of a human MC line, LAD2. Antibody-based fluorescent lifetime imaging microscopy confirmed complexes containing both receptors based on fluorescence energy transfer. Negative regulation of CysLT(1)-induced mitogenic signaling responses of MCs by CysLT(2) demonstrates physiologically relevant functions for GPCR heterodimers on primary cells central to inflammation.
Jiang
Yongfeng
Y
Department of Medicine, Harvard Medical School, Boston, MA, USA.
Borrelli
Laura A
LA
Kanaoka
Yoshihide
Y
Bacskai
Brian J
BJ
Boyce
Joshua A
JA
D000818:Animals; D049109:Cell Proliferation / Q000187:drug effects; D002478:Cells, Cultured; D003545:Cysteine / Q000378:metabolism / Q000494:pharmacology*; D048049:Extracellular Signal-Regulated MAP Kinases / Q000378:metabolism; D006367:HeLa Cells; D006801:Humans; D017998:Leukotriene D4 / Q000494:pharmacology; D015289:Leukotrienes / Q000378:metabolism / Q000494:pharmacology*; D008407:Mast Cells / Q000166:cytology / Q000187:drug effects*; D008565:Membrane Proteins / Q000235:genetics / Q000378:metabolism* / Q000502:physiology*; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008938:Mitosis / Q000187:drug effects*; D011485:Protein Binding; D019009:Proto-Oncogene Proteins c-kit / Q000378:metabolism; D018077:Receptors, Leukotriene / Q000235:genetics / Q000378:metabolism* / Q000502:physiology*; D015533:Transcriptional Activation / Q000187:drug effects
D015289:Leukotrienes; D008565:Membrane Proteins; D018077:Receptors, Leukotriene; C112381:cysteinyl-leukotriene; D017998:Leukotriene D4; C412375:cysteinyl leukotriene receptor 2; D019009:Proto-Oncogene Proteins c-kit; D048049:Extracellular Signal-Regulated MAP Kinases; D003545:Cysteine; C083169:leukotriene D4 receptor
Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7964-9
11438743
J Biol Chem. 2000 Sep 29;275(39):30531-6
10851239
J Biol Chem. 2002 Jun 7;277(23):20820-4
11932261
Leuk Res. 2003 Aug;27(8):677-82
12801524
J Neurosci. 2003 Jun 1;23(11):4560-6
12805296
J Biomed Opt. 2003 Jul;8(3):368-75
12880341
Clin Exp Allergy. 2003 Oct;33(10):1380-8
14519144
Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11589-93
13679572
J Neurosci. 2001 Feb 15;21(4):1203-10
11160390
J Biol Chem. 2001 Jun 22;276(25):22608-13
11319240
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3047-52
14970333
Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6587-92
15084748
J Biol Chem. 2004 Jul 2;279(27):28756-65
15123695
Nat Med. 2004 Oct;10(10):1065-6
15448688
Pharmacogenetics. 2004 Sep;14(9):627-33
15475736
J Biol Chem. 2004 Oct 29;279(44):46129-34
15328359
Blood. 1978 Aug;52(2):447-52
352443
J Clin Invest. 1987 Nov;80(5):1507-11
3680512
Am Rev Respir Dis. 1992 Sep;146(3):577-80
1519831
J Allergy Clin Immunol. 1998 Aug;102(2):177-83
9723658
Nature. 1999 Jun 24;399(6738):789-93
10391245
J Exp Med. 1999 Jul 19;190(2):267-80
10432289
Autoimmun Rev. 2005 Jan;4(1):21-7
15652775
J Allergy Clin Immunol. 2005 Feb;115(2):316-22
15696087
Cancer Res. 2005 Feb 1;65(3):732-42
15705869
J Immunol. 2005 Oct 15;175(8):5430-8
16210650
Biochem Pharmacol. 2005 Dec 19;71(1-2):115-25
16280122
J Immunol. 2006 Apr 1;176(7):4440-8
16547282
J Immunol. 2006 May 1;176(9):5167-71
16621980
J Clin Invest. 2006 May;116(5):1400-9
16670773
J Immunol. 2006 Sep 1;177(5):2755-9
16920908
EMBO J. 2006 Oct 4;25(19):4615-27
16990797
Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16394-9
17050692
J Allergy Clin Immunol. 2007 Jan;119(1):132-40
17208594
J Exp Med. 2002 Mar 4;195(5):583-92
11877481